Sustainability News

Sustainability News

  • November 29, 2024 Sustainability Information
  • May 9, 2024 The Global Health Innovative Technology Fund provides grant to Mitsubishi Tanabe Pharma and DNDi for Chagas disease drug discovery
  • November 7, 2023 Sustainability Information
  • July 10, 2023 Material Issues, Monitoring Indicators and FY2022 Results
  • April 11, 2023 Support for the Earthquake Victims in Turkey and Syria
  • November 21, 2022 Sustainability Information
  • August 30, 2022 Material Issues, Monitoring Indicators and FY2021 Results
  • July 13, 2022 Humanitarian Donation to Ukraine
  • December 7, 2021 Sustainability Information
  • March 31, 2021 The Global Health Innovative Technology Fund provides grant to Mitsubishi Tanabe Pharma and DNDi for Chagas disease and leishmaniasis drug discovery ~Targeting treatments for infectious diseases that impact people in developing countries~
  • October 26, 2020 Sustainability Information
  • September 30, 2019 Mitsubishi Tanabe Pharma to participate in new screening program through the Global Health Innovative Technology Fund ~Targeting treatments for infectious diseases that burden the developing countries~ pdf (378KB)
  • September 18, 2019 Mitsubishi Tanabe Pharma Included in the Dow Jones Sustainability Asia Pacific Index
  • March 28, 2019 The Global Health Innovative Technology Fund provides grant for joint research into anti-malarial drugs conducted by Mitsubishi Tanabe Pharma and a malaria research institution
  • February 25, 2019 Receipt of the Award of Merit in the Environmental Report Section of the 22st Environmental Communication Awards
  • February 22, 2019 Selected as "Outstanding Enterprise in Health and Productivity Management — White 500" For the Third Consecutive Year
  • September 18, 2018 Mitsubishi Tanabe Pharma Included in the Dow Jones Sustainability Asia Pacific Index
  • March 8, 2018 Support Activities for Refractory Disease Patient Organizations: The Mitsubishi Tanabe Pharma Tenohira Partnership Program Notice Regarding Determination of Aid Recipients for the Sixth Year(Fiscal 2018)
  • March 1, 2018 Selected as "Outstanding Enterprise in Health and Productivity Management — White 500" For the Second Consecutive Year
  • February 28, 2018 Receipt of the Award of Merit in the Environmental Report Section of the 21st Environmental Communication Awards ~ Mitsubishi Tanabe Pharma Corporate Report 2017 and CSR Activities Report 2017 ~
  • June 1, 2017 Mitsubishi Tanabe Pharma contribute funding to Global Health Innovative Technology Fund’s second phase ―Targeting treatments for infectious diseases that burden the developing world―
  • June 6, 2016 Mitsubishi Tanabe Pharma contribute funding to Global Health Innovative Technology Fund
  • May 22, 2015 Mitsubishi Tanabe Pharma provides Compound Library to Screening Program of Global Health Innovative Technology Fund
  • March 14, 2011 Mitsubishi Tanabe Pharma Supports Japan Earthquake Relief Efforts
  • February 10, 2010 Tianjin Tanabe Seiyaku Receives ISO 14001 Certification
  • January 25, 2010 Mitsubishi Tanabe Pharma Supports Relief Efforts for Haiti Earthquake Disaster

Tanabe Pharma issues its news to provide stakeholders with the latest information related to the Company. Information on products or drug candidates may be included, but is intended to provide for the media, etc. It is not intended for promotion, advertising or medical advice. Information is current as of the date of issue of the individual news. Please be advised that information may be outdated after that point.

  1. Tanabe Pharma Corporation
  2. Sustainability
  3. Sustainability News
  • header-content
  • header-content

  • CLOSE
  • MENU

Site Search

If you agree to the use of cookies, please click the "Agree" button.
If you do not agree, please do not use this site. For details, please refer to the following page.

Privacy Policy

Agree

URL
 

田辺ファーマ株式会社のサイトを離れます。よろしいですか?
(別ウィンドウが開きます)

You are leaving the Tanabe Pharma Corporation’s website.
(A new window will be opened.)

はい / O.K.
いいえ / Cancel
  • footer-content